Correlation Between Vicore Pharma and Alligator Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vicore Pharma and Alligator Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vicore Pharma and Alligator Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vicore Pharma Holding and Alligator Bioscience AB, you can compare the effects of market volatilities on Vicore Pharma and Alligator Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vicore Pharma with a short position of Alligator Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vicore Pharma and Alligator Bioscience.

Diversification Opportunities for Vicore Pharma and Alligator Bioscience

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vicore and Alligator is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Vicore Pharma Holding and Alligator Bioscience AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alligator Bioscience and Vicore Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vicore Pharma Holding are associated (or correlated) with Alligator Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alligator Bioscience has no effect on the direction of Vicore Pharma i.e., Vicore Pharma and Alligator Bioscience go up and down completely randomly.

Pair Corralation between Vicore Pharma and Alligator Bioscience

Assuming the 90 days trading horizon Vicore Pharma Holding is expected to generate 0.57 times more return on investment than Alligator Bioscience. However, Vicore Pharma Holding is 1.75 times less risky than Alligator Bioscience. It trades about 0.11 of its potential returns per unit of risk. Alligator Bioscience AB is currently generating about 0.05 per unit of risk. If you would invest  633.00  in Vicore Pharma Holding on April 22, 2025 and sell it today you would earn a total of  146.00  from holding Vicore Pharma Holding or generate 23.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vicore Pharma Holding  vs.  Alligator Bioscience AB

 Performance 
       Timeline  
Vicore Pharma Holding 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vicore Pharma Holding are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Vicore Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.
Alligator Bioscience 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Alligator Bioscience AB are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Alligator Bioscience unveiled solid returns over the last few months and may actually be approaching a breakup point.

Vicore Pharma and Alligator Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vicore Pharma and Alligator Bioscience

The main advantage of trading using opposite Vicore Pharma and Alligator Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vicore Pharma position performs unexpectedly, Alligator Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alligator Bioscience will offset losses from the drop in Alligator Bioscience's long position.
The idea behind Vicore Pharma Holding and Alligator Bioscience AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments